Patrick Williams
Known title: DirectorCIK: 0001338883
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Innospec schedules Q3 2026 earnings release and call. Innospec has announced the date for its third-quarter 2026 earnings release and conference call. The company recently completed its Q2 2026 earnings call, providing the latest update on its performance. This upcoming event will likely offer further insight into the firm's operational outlook.
Transaction History
| ASIX | ▲ Buy | Grant | 785 | $13K | 10/6/2026 | View on chart |
| ASIX | ▲ Buy | Grant | 660 | $13K | 6/30/2026 | View on chart |
| ASIX | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 | View on chart |
| ASIX | ▲ Buy | Grant | 537 | $13K | 3/31/2026 | View on chart |
| IOSP | ▼ Sell | Tax Withholding | 7,966 | $624K | 2/27/2026 | View on chart |
| IOSP | ▲ Buy | Grant | 20,846 | $0 | 2/23/2026 | View on chart |
| IOSP | ▲ Buy | Grant | 18,966 | $0 | 2/16/2026 | View on chart |
| ASIX | ▲ Buy | Grant | 821 | $13K | 12/15/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 677 | $13K | 9/30/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 552 | $13K | 6/30/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 579 | $13K | 3/31/2025 | View on chart |
| IOSP | ▼ Sell | Tax Withholding | 12,723 | $1.3M | 3/3/2025 | View on chart |
| IOSP | ▲ Buy | Grant | 14,743 | $0 | 2/24/2025 | View on chart |
| IOSP | ▲ Buy | Grant | 30,292 | $0 | 2/21/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 430 | $13K | 12/16/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 432 | $13K | 9/30/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 572 | $13K | 6/28/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 458 | $13K | 3/28/2024 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 3,955 | $395K | 2/29/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 3,955 | $491K | 2/29/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 4,095 | $508K | 2/27/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 5,572 | $695K | 2/27/2024 | View on chart |
| IOSP | ▲ Buy | Grant | 12,216 | $0 | 2/26/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 4,165 | $519K | 2/26/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 5,402 | $677K | 2/26/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 100 | $13K | 2/26/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 2,757 | $341K | 2/23/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 6,899 | $860K | 2/23/2024 | View on chart |
| IOSP | ▼ Sell | Open Market | 11 | $1K | 2/23/2024 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 1,318 | $132K | 2/22/2024 | View on chart |
| IOSP | ▼ Sell | Other | 1,318 | $163K | 2/22/2024 | View on chart |
| IOSP | ▲ Buy | Grant | 29,001 | $0 | 2/22/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 447 | $13K | 12/15/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 422 | $13K | 9/29/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 393 | $14K | 6/30/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 293 | $11K | 3/31/2023 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 3,967 | $0 | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 2,201 | $238K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 2,610 | $284K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,320 | $145K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,341 | $149K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,159 | $125K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,377 | $150K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 714 | $78K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 717 | $80K | 3/3/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 3,853 | $418K | 3/2/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 6,293 | $686K | 3/2/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,294 | $142K | 3/2/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 4,540 | $496K | 3/1/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 4,328 | $476K | 3/1/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 275 | $30K | 3/1/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 3,415 | $376K | 2/28/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 5,444 | $604K | 2/28/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 287 | $32K | 2/28/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 21 | $2K | 2/27/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 501 | $55K | 2/27/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 6,699 | $745K | 2/27/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,925 | $215K | 2/27/2023 | View on chart |
| IOSP | ▲ Buy | Grant | 1,326 | $0 | 2/27/2023 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 1,323 | $127K | 2/24/2023 | View on chart |
| IOSP | ▼ Sell | Other | 1,323 | $145K | 2/24/2023 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 36,581 | $0 | 2/24/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 1,862 | $200K | 2/24/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 3,405 | $369K | 2/24/2023 | View on chart |
| IOSP | ▼ Sell | Open Market | 3,879 | $424K | 2/24/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 290 | $11K | 12/15/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 351 | $11K | 9/30/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 336 | $11K | 6/30/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 2,714 | $0 | 6/15/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 220 | $11K | 3/31/2022 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 10,765 | $0 | 2/25/2022 | View on chart |
| IOSP | ▼ Sell | Open Market | 6,400 | $619K | 2/25/2022 | View on chart |
| IOSP | ▼ Sell | Open Market | 600 | $58K | 2/25/2022 | View on chart |
| IOSP | ▲ Buy | Option Exercise | 4,448 | $361K | 2/25/2022 | View on chart |
| IOSP | ▼ Sell | Open Market | 4,033 | $390K | 2/25/2022 | View on chart |
| IOSP | ▼ Sell | Open Market | 415 | $40K | 2/25/2022 | View on chart |
| IOSP | ▲ Buy | Grant | 1,377 | $0 | 2/21/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 259 | $11K | 12/17/2021 | View on chart |
| IOSP | ▼ Sell | Open Market | 2,379 | $220K | 11/9/2021 | View on chart |
| IOSP | ▼ Sell | Open Market | 9,021 | $844K | 11/9/2021 | View on chart |
| IOSP | ▼ Sell | Open Market | 600 | $56K | 11/9/2021 | View on chart |
| ASIX | ▲ Buy | Grant | 283 | $11K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge
AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge. AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.